Appetite and General Nutritional Disorders Clinical Trial
Official title:
Short-term Positive Energy Balance and Exercise on 24-hour Plasma Levels of Hunger and Satiety Hormones in Sedentary Lean and Obese Men and Women
Verified date | July 2013 |
Source | University of Wisconsin, Madison |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The purpose of this research study is to examine the effects of overfeeding and exercise on
blood levels of hormones associated with regulating appetite, also thought of as feelings of
hunger and satiety (fullness). Previous studies have shown that non-obese people have
different amounts of these hormones in their blood compared to obese people.
The investigators hypothesize that exercise will promote improved insulin sensitivity and
corresponding beneficial changes in obese individuals. The investigators predict exercise
induced changes in 24-hour plasma hormone levels will be associated with improved appetite
during overfeeding in obese individuals.
Status | Completed |
Enrollment | 13 |
Est. completion date | February 2012 |
Est. primary completion date | November 2011 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 39 Years |
Eligibility |
Inclusion Criteria: - Healthy body mass index (BMI) = 19 < 25 kg/m2 - Obese BMI = 30 < 35 kg/m2 - Activity level = sedentary: Total energy expenditure/resting metabolic rate < 1.6 (average US adult level) Exclusion Criteria: - Tobacco use - Regular exercise or physical activity, defined as > 2h/week of moderate to vigorous activity; - Individuals who do not eat breakfast - Weight loss of > 3% of body weight over the previous six months - Eating a special diet (e.g., vegetarian or low-carbohydrate) - Current diagnosis of, or using prescription medications for, thyroid dysfunction, type I or type II diabetes, hypertension, cardiovascular, kidney, or liver disease; - Taking other prescription medications or over-the-country products that alter energy metabolism (other than birth control pills) - Allergies to any of the foods used in the study - Individuals who donated blood within 8 weeks prior to enrollment or who plan to give blood during the course of the study - Claustrophobia - History of exercise intolerance, including diagnosed exercise induced asthma or any physical limitations to seated cycling aerobic exercise - Blood chemistries in excess of 130% of the upper normal level and/or hemoglobin or hematocrit below the normal range. - Females that are pregnant (pregnancy status to be tested at the beginning of each 6-day metabolic chamber stay), lactating, or have irregular menses |
Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Country | Name | City | State |
---|---|---|---|
United States | University of Wisconsin Hospitals, Clinical and Translational Research Core (CTRC) | Madison | Wisconsin |
Lead Sponsor | Collaborator |
---|---|
University of Wisconsin, Madison |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Blood plasma appetite hormone concentrations | Blood samples will be drawn over 24 hours on the third and sixth day of each inpatient visit. | Two separate six day & seven night inpatient visits, separated by at least 4 weeks. | No |
Secondary | Perceived subjective appetite measured by visual analog scales | Appetite questionnaires will be filled out hourly as well as every 30 minutes after meals from 8:00am to 11:00pm on the third and sixth day of each inpatient visit. | Two separate six day & seven night inpatient visits, separated by at least 4 weeks. | No |
Secondary | Energy intake at a breakfast buffet | A breakfast buffet will be served the morning after day 3 and day 6 of each inpatient visit to assess food intake following either energy balance (days 1-3) or overfeeding (days 4-6) with or without daily exercise. | Two separate six day inpatient visits, separated by at least 4 weeks. | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06146322 -
Barley Beta-glucan, Glycemic Control, and Appetite
|
N/A | |
Completed |
NCT01900340 -
Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
|
Phase 1 | |
Completed |
NCT02285907 -
Protein Quality on Appetite Control, Reward-driven Eating, & Subsequent Food Intake
|
N/A | |
Suspended |
NCT03031132 -
The Effects of a High Protein Breakfast on Appetite and Sleep in Young Adults
|
N/A | |
Completed |
NCT04876495 -
The Effects of Whey, Rice and Potato pRotein isOlates on appeTite rEgulatIoN in Healthy Men
|
N/A | |
Recruiting |
NCT03009695 -
Transcranial Magnetic Stimulation (TMS) in Obesity
|
N/A | |
Recruiting |
NCT02075827 -
Metabolic Response to Playing Video Games: Two Arm Trial
|
N/A | |
Withdrawn |
NCT01946841 -
Specific Enteral Nutrition in Malnourished, Dialysis Patients With Chronic Kidney Disease. Efficacy, Safety, Quality of Life
|
Phase 2 | |
Completed |
NCT01088841 -
Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY
|
Phase 1 |